- Home
- ORLA vs SRRK Comparison
ORLA vs SRRK Comparison
Compare ORLA & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORLA | SRRK |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ORLA | SRRK |
|---|---|---|
| Price | $13.55 | $44.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $27.00 | ★ $47.00 |
| AVG Volume (30 Days) | 2.0M | ★ 2.1M |
| Earning Date | 11-11-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2239.45 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $772,153,000.00 | N/A |
| Revenue This Year | $183.80 | N/A |
| Revenue Next Year | $36.88 | $20,271.77 |
| P/E Ratio | $82.46 | ★ N/A |
| Revenue Growth | ★ 145.83 | N/A |
| 52 Week Low | $5.25 | $22.71 |
| 52 Week High | $14.36 | $48.28 |
Technical Indicators
Market Signals| Indicator | ORLA | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 59.52 | 62.15 |
| Support Level | $11.99 | $43.92 |
| Resistance Level | $14.36 | $48.28 |
| Average True Range (ATR) | 0.66 | 2.17 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 66.58 | 59.98 |
Price Performance
Historical ComparisonAbout ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.